Behavioral
Summit Medical Group, INC
Summit Medical Group, INC was paid $94.78M by Medicaid between Jan 2018 and Dec 2024, across 281 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 29% of everything it billed.
33Billing provider infoSUMMIT MEDICAL GROUP, INC
ERLANGER, KY 41018
ERLANGER, KY 41018
33aNPI1750343216assigned 04/03/2006
33bProvider typeMental Health Counselor
28Total paid$94.78M
24GClaims2,550,874
24DCodes billed281
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Mental Health Counselor providers in Kentucky
Rank by total paid#2 of 204
Median peer was paid$135K
This provider vs. median701×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 327,056 | $10.62M | |
| 2019 | 349,814 | $11.55M | |
| 2020 | 330,140 | $12.07M | |
| 2021 | 421,350 | $16.09M | |
| 2022 | 408,803 | $15.58M | |
| 2023 | 407,398 | $16.01M | |
| 2024incomplete | 306,313 | $12.85M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 29% | 748,404 | 672,568 | $27.40M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 23% | 445,117 | 404,007 | $22.15M |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 7.4% | 248,208 | 104,565 | $7.03M |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 4.4% | 104,486 | 54,519 | $4.16M |
| 99223 | Prolong inpt eval add15 m | 3.7% | 41,513 | 38,648 | $3.50M |
| 99239 | Hospital discharge day management, more than 30 minutes | 2.4% | 45,032 | 41,399 | $2.27M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.7% | 20,565 | 19,787 | $1.58M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.7% | 40,717 | 39,942 | $1.58M |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | 1.6% | 45,446 | 35,725 | $1.52M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.6% | 21,980 | 20,912 | $1.50M |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 1.2% | 10,819 | 4,636 | $1.13M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.2% | 13,605 | 12,526 | $1.12M |
269 more codes
| J0585 | Injection, onabotulinumtoxina, 1 unit | 1.1% | 2,228 | $1.09M |
| 99254 | 1.1% | 12,468 | $1.07M | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1.1% | 146,632 | $1.01M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 12,315 | $932K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 10,601 | $868K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 49,595 | $774K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 18,644 | $738K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 6,242 | $721K |
| 90461 | <1% | 15,878 | $670K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 9,641 | $570K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 37,714 | $545K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 8,239 | $535K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 19,644 | $517K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 12,094 | $480K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 30,282 | $431K |
| 59025 | Fetal non-stress test | <1% | 16,798 | $390K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 4,105 | $387K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 4,878 | $361K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 3,951 | $329K |
| 90837 | Psychotherapy session, about an hour | <1% | 4,553 | $309K |
| 95886 | <1% | 5,400 | $301K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 21,289 | $297K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 2,583 | $279K |
| 59426 | <1% | 3,495 | $278K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 10,160 | $259K |
| 99255 | <1% | 2,254 | $254K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 16,143 | $253K |
| 87400 | <1% | 10,429 | $250K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 13,049 | $235K |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | <1% | 355 | $220K |
| 59425 | <1% | 2,341 | $197K | |
| 99253 | <1% | 3,279 | $189K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 1,890 | $184K |
| 80305 | <1% | 17,708 | $183K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 9,290 | $183K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 2,030 | $143K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 3,295 | $142K |
| 99205 | Prolong outpt/office vis | <1% | 1,351 | $131K |
| 62323 | <1% | 1,815 | $129K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 3,794 | $129K |
| 64493 | <1% | 1,501 | $123K | |
| 11102 | <1% | 1,864 | $104K | |
| 87428 | <1% | 2,363 | $97K | |
| 95811 | <1% | 850 | $95K | |
| 64615 | <1% | 1,247 | $86K | |
| 90686 | <1% | 17,673 | $84K | |
| 64635 | <1% | 396 | $80K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 1,213 | $76K |
| 93000 | <1% | 5,858 | $75K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 1,650 | $71K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 1,805 | $70K |
| 64494 | <1% | 1,512 | $67K | |
| 11043 | <1% | 962 | $62K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 5,079 | $56K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 436 | $55K |
| 90682 | <1% | 1,338 | $54K | |
| 93295 | <1% | 1,665 | $52K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 9,732 | $50K |
| 96127 | <1% | 7,268 | $46K | |
| 51701 | <1% | 1,466 | $45K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 1,163 | $44K |
| 95251 | <1% | 3,021 | $43K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 1,081 | $43K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 3,275 | $39K |
| 47562 | <1% | 94 | $37K | |
| 99454 | <1% | 1,073 | $37K | |
| 93971 | <1% | 2,248 | $37K | |
| 99348 | <1% | 923 | $36K | |
| 99243 | <1% | 564 | $36K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 7,292 | $34K |
| 99457 | <1% | 1,063 | $32K | |
| 95911 | <1% | 362 | $31K | |
| 99497 | <1% | 865 | $28K | |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 72 | $27K |
| H0015 | Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education | <1% | 559 | $26K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 459 | $26K |
| 90688 | <1% | 6,135 | $25K | |
| 17110 | <1% | 1,082 | $24K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 3,058 | $24K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 246 | $23K |
| 64636 | <1% | 418 | $22K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,188 | $20K |
| 93016 | <1% | 1,284 | $19K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 92 | $18K |
| 92133 | <1% | 987 | $18K | |
| 81025 | <1% | 2,832 | $17K | |
| 94726 | <1% | 2,074 | $17K | |
| 54150 | <1% | 223 | $16K | |
| 99221 | <1% | 460 | $16K | |
| 95910 | <1% | 214 | $15K | |
| 93018 | <1% | 1,275 | $15K | |
| 90474 | <1% | 1,557 | $15K | |
| 98928 | <1% | 413 | $14K | |
| 20553 | <1% | 581 | $14K | |
| 92083 | <1% | 468 | $14K | |
| 99458 | <1% | 386 | $13K | |
| 11721 | <1% | 1,186 | $13K | |
| 99245 | <1% | 85 | $12K | |
| 93970 | <1% | 621 | $12K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 961 | $12K |
| 17000 | <1% | 497 | $12K | |
| 83655 | <1% | 921 | $12K | |
| 97803 | <1% | 540 | $12K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 93 | $11K |
| 99406 | <1% | 1,611 | $11K | |
| 93294 | <1% | 800 | $11K | |
| 81002 | <1% | 3,748 | $10K | |
| 94010 | <1% | 1,068 | $10K | |
| 11100 | <1% | 383 | $10K | |
| 94729 | <1% | 1,867 | $10K | |
| 95816 | <1% | 339 | $10K | |
| 90739 | <1% | 99 | $10K | |
| 99220 | <1% | 128 | $10K | |
| 76801 | <1% | 179 | $10K | |
| 90677 | <1% | 1,882 | $9K | |
| T2023 | Targeted case management; per month | <1% | 32 | $9K |
| 99252 | <1% | 209 | $9K | |
| 99385 | <1% | 104 | $9K | |
| 95806 | <1% | 116 | $9K | |
| 93298 | <1% | 495 | $9K | |
| 99335 | <1% | 504 | $9K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 73 | $8K |
| 93296 | <1% | 468 | $8K | |
| 73630 | <1% | 409 | $8K | |
| 90670 | <1% | 11,615 | $8K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 623 | $7K |
| 87807 | <1% | 605 | $7K | |
| 84703 | <1% | 1,061 | $7K | |
| 17311 | <1% | 26 | $7K | |
| 90836 | <1% | 219 | $7K | |
| 64483 | <1% | 49 | $7K | |
| 51798 | <1% | 883 | $6K | |
| 99188 | <1% | 408 | $6K | |
| 76519 | <1% | 299 | $6K | |
| 90656 | <1% | 1,509 | $6K | |
| 80320 | <1% | 1,029 | $6K | |
| 95819 | <1% | 215 | $6K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 160 | $5K |
| 93458 | <1% | 29 | $5K | |
| 99334 | <1% | 564 | $5K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 72 | $5K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 211 | $5K |
| 90632 | <1% | 89 | $4K | |
| 81003 | <1% | 2,490 | $4K | |
| 98929 | <1% | 100 | $4K | |
| 85018 | <1% | 1,519 | $4K | |
| 99242 | <1% | 75 | $3K | |
| 59430 | <1% | 21 | $3K | |
| 93227 | <1% | 125 | $3K | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 374 | $3K |
| 92134 | <1% | 144 | $3K | |
| 99459 | <1% | 251 | $3K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 28 | $3K |
| 0124A | <1% | 113 | $3K | |
| 99051 | <1% | 1,246 | $3K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 62 | $3K |
| 0071A | <1% | 72 | $3K | |
| 93297 | <1% | 234 | $3K | |
| 0072A | <1% | 68 | $3K | |
| 99173 | <1% | 106 | $2K | |
| 92551 | <1% | 202 | $2K | |
| 0011A | <1% | 72 | $2K | |
| 17003 | <1% | 108 | $2K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 30 | $2K |
| 99417 | Prolong home eval add 15m | <1% | 85 | $2K |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 13 | $2K |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 494 | $2K |
| 20550 | <1% | 43 | $2K | |
| 90698 | <1% | 7,782 | $2K | |
| 27096 | <1% | 13 | $2K | |
| 99307 | <1% | 470 | $2K | |
| 90961 | <1% | 31 | $2K | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 154 | $2K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 26 | $2K |
| 99407 | <1% | 74 | $2K | |
| 93880 | <1% | 130 | $2K | |
| 11103 | <1% | 35 | $2K | |
| 90785 | <1% | 283 | $2K | |
| 20610 | <1% | 38 | $1K | |
| 99251 | <1% | 64 | $1K | |
| 0012A | <1% | 42 | $1K | |
| 68761 | <1% | 96 | $1K | |
| 91320 | <1% | 13 | $1K | |
| 95909 | <1% | 27 | $1K | |
| 99152 | <1% | 134 | $1K | |
| 95250 | <1% | 51 | $1K | |
| 90715 | <1% | 166 | $1K | |
| 99460 | <1% | 31 | $1K | |
| 99386 | <1% | 14 | $1K | |
| 90651 | <1% | 580 | $1K | |
| 52000 | <1% | 16 | $1K | |
| 11104 | <1% | 15 | $1K | |
| 90680 | <1% | 5,392 | $1K | |
| 76830 | Ultrasound, transvaginal | <1% | 15 | $1K |
| 93923 | <1% | 57 | $1K | |
| 86580 | <1% | 199 | $1K | |
| 99218 | <1% | 23 | $1K | |
| 82044 | <1% | 242 | $1K | |
| 90734 | <1% | 416 | $1K | |
| 0064A | <1% | 45 | $958.32 | |
| 90480 | <1% | 27 | $954.90 | |
| 99349 | <1% | 34 | $932.43 | |
| 90732 | <1% | 12 | $897.16 | |
| 92136 | <1% | 46 | $805.48 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 27 | $787.80 |
| 92250 | <1% | 26 | $774.99 | |
| 92015 | Determination of refractive state | <1% | 81 | $743.00 |
| 90710 | <1% | 1,397 | $662.09 | |
| 0134A | <1% | 19 | $620.00 | |
| 96415 | <1% | 15 | $592.62 | |
| 90746 | <1% | 13 | $549.33 | |
| 82570 | <1% | 137 | $530.51 | |
| 99305 | <1% | 44 | $512.18 | |
| 90621 | <1% | 30 | $497.90 | |
| 99337 | <1% | 38 | $465.54 | |
| 90633 | <1% | 5,245 | $464.41 | |
| 90685 | <1% | 725 | $445.24 | |
| 99217 | <1% | 14 | $427.52 | |
| 76514 | <1% | 71 | $414.72 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 283 | $384.26 |
| 93308 | <1% | 13 | $384.07 | |
| 82465 | <1% | 75 | $382.24 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 88 | $377.09 |
| 98927 | <1% | 14 | $367.96 | |
| 99347 | <1% | 40 | $328.36 | |
| 92020 | <1% | 57 | $324.76 | |
| 99443 | <1% | 53 | $318.35 | |
| 99336 | <1% | 39 | $315.31 | |
| 11900 | <1% | 14 | $314.87 | |
| 90473 | <1% | 16 | $279.24 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 239 | $278.50 |
| 76604 | <1% | 13 | $270.69 | |
| 46600 | <1% | 15 | $268.41 | |
| 90697 | <1% | 1,377 | $265.54 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 32 | $260.20 |
| 92552 | <1% | 16 | $208.05 | |
| 94060 | <1% | 13 | $206.26 | |
| 82962 | <1% | 65 | $157.45 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 238 | $150.71 |
| 76937 | <1% | 29 | $140.30 | |
| 93228 | <1% | 13 | $136.56 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 105 | $123.71 |
| 91200 | <1% | 12 | $121.46 | |
| 99310 | Prolong nursin fac eval 15m | <1% | 33 | $111.74 |
| 99177 | <1% | 28 | $101.16 | |
| 90744 | <1% | 1,618 | $87.54 | |
| 99318 | <1% | 20 | $72.39 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 54 | $68.96 |
| 90696 | <1% | 114 | $23.00 | |
| G8482 | Influenza immunization administered or previously received | <1% | 678 | $20.51 |
| 3017F | <1% | 761 | $20.51 | |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | <1% | 5,981 | $13.86 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 15 | $1.71 |
| J2315 | Injection, naltrexone, depot form, 1 mg | <1% | 942 | $0.04 |
| 90700 | <1% | 25 | $0.01 | |
| G8484 | Influenza immunization was not administered, reason not given | 0% | 1,326 | $0.00 |
| 90687 | 0% | 233 | $0.00 | |
| G8598 | Aspirin or another antiplatelet therapy used | 0% | 50 | $0.00 |
| 4040F | 0% | 123 | $0.00 | |
| 91312 | 0% | 83 | $0.00 | |
| G8421 | Bmi not documented and no reason is given | 0% | 104 | $0.00 |
| 90672 | 0% | 16 | $0.00 | |
| 91313 | 0% | 18 | $0.00 | |
| 2022F | 0% | 12 | $0.00 | |
| G8432 | Depression screening not documented, reason not given | 0% | 2,227 | $0.00 |
| 1101F | 0% | 257 | $0.00 | |
| 90619 | 0% | 44 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 25 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 85 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRANKIN, MARIA (AVP-REVENUE CYCLE)
| Provider | Location | Paid |
|---|---|---|
| Summit Medical Group, INC. | Highland Heights, KY | $4.74M |
| Summit Medical Group, INC | Covington, KY | $4.23M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.